7733Olympus Corporation

🇯🇵 Japonya Borsası
1719.00
JPY
Analysis Scores
Lothien Robustness Score?
66/100
Strong
Neden bu skor?
Damodaran ?
68/100
Dalio Risk ?
84/100
Piotroski ?
4/9
Neutral
Operating cash flow data missing (C3, C4); gross profit, revenue data missing → margin comparison unavailable (C8); revenue data missing → turnover calculation unavailable (C9)
Graham ?
¥1,013.6
Pahalı
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
59/100
Lothien Sağlamlık: Orta (59/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 3 | Negatif: 1 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte ¥24.8B net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+75.1 arttı (¥14.2B → ¥24.8B). Kısa vadede olumlu momentum.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+206.0 arttı. Şirket büyüyor.
Düşük Nakit Dönüşümü
FCF/Kâr oranı sadece %18. Kâr kâğıt üzerinde, nakte dönmüyor.
Mevsimsel Toparlanma, Ama Trend Bozuk
Çeyreklik artış (%+75.1) ama yıllık bazda düşüş (%-15.8). Mevsimsel toparlanma var ama uzun vadeli trend zayıf.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-35.1 düşebilir. Sonraki bilançoya dikkat.

Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-23
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Yüksek
252 days
Annual Volatility ?
%44.2
VaR 95% ?
%4.58
daily max loss
VaR 99% ?
%6.48
daily max loss
CVaR 95% ?
%5.49
expected loss (tail)
Max Drawdown ?
%38.1
26.11.2025 → 13.03.2026
Skewness ?
1.19
Parametrik%4.58
Historik%3.15
Cornish-Fisher%2.77
Return Distribution
Valuation
Potential?
+22.1%
ROIC ?
15.3%
DCF Value ?
3,293.18
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Son 7 çeyrek ardışık kâr
Fiyat TRAMA-99 hafif altında: %-0.9
Direnç seviyesi: TRAMA-99 = 1735.05 JPY
Fundamental & Technical Analysis
Profitability
Net Profit Margin %3.3
Net profit margin %3.3 — positive but low.
ROE - Return on Equity (TTM) %7.7
ROE %7.7 — low return on equity.
EBITDA Margin %18.0
EBITDA margin %18.0 — good operational performance.
Gross Profit Margin %64.6
Gross profit per revenue %64.6. Strong pricing power.
Free Cash Flow Margin (TTM) %5.6
TTM Free Cash Flow is %5.6'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio 26.2x Sector: 20.8x
F/K 26.2x — sector median's (20.8x) %26 above. Slight premium.
P/B Ratio 2.20x Sector: 2.35x
PD/DD 2.20x — sector median (2.35x) below or near. Reasonable valuation.
EV/EBITDA 6.4x Sector: 9.5x
EV/EBITDA 6.4x — sector median's (9.5x) %32 below. Cheap relative to EBITDA.
Indebtedness
Current Ratio 1.62x
Current ratio 1.62x — can comfortably cover short-term debts.
Net Debt / EBITDA 0.8x
Net Debt/EBITDA 0.8x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.30x
Low leverage — majority of assets financed by equity.
Interest Coverage 17.2x
Interest coverage 17.2x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+206.0
Revenue YoY %206.0 grew (2026/3) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %-15.8
Net profit YoY %-15.8 declined — profitability under pressure.
Seasonality Analysis Q1 (Oca-Mar)
Historically strongest quarter: Q1 (Jan-Mar) (avg. profit 38.3B). Weakest quarter: Q2 (Apr-Jun) (avg. profit 19.2B).
Score Explanations
Lothien Robustness
66/100
Good robustness (66/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+22.1%
Plus %22.1 expected value (2055.69) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 1474.06 | P/B target: 1827.44 | EV/EBITDA target: 2488.84 | DCF target: 3293.18
Damodaran Valuation
68/100
Moderate Damodaran score (68/100). ROIC (%15.3) – WACC (%6.2) difference +9.1 bps. Value creation capacity limited.
Strong
Dalio Risk Analysis
84/100
Low debt risk (84/100). Interest coverage ratio 17.2x — strong. Debt/EBITDA 0.8x — in healthy range.
Leverage: 84/100 | Debt Service: 90/100 | Quality: 81/100
ROIC - Return on Capital
%15.3
ROIC (%15.3) cost of capital 9.1 bps above → company creates value.
WACC: %6.2
DCF Discounted Cash Flow
3,293.18
DCF modeli 3293.18 target value produced — compared to current price %95.7 undervalued.
Current price: 1683.00
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Operating cash flow data missing (C3, C4); gross profit, revenue data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
¥1,013.6
Expensive
⚖️ Sector Comparison
P/E Ratio
26.2x vs 20.8x
Sector median's %26 above — expensive
P/B Ratio
2.20x vs 2.35x
Compared to sector %6 cheaper (by book value)
EV/EBITDA
6.4x vs 9.5x
Compared to sector %32 lower EV/EBITDA
ROIC vs WACC
%15.3 vs %6.2 WACC
ROIC 9.1 bps above cost of capital
Net Profit Margin (TTM)
%6.9 vs %19.0 EBITDA margin
TTM net profit margin %6.9
↔
TRAMA-99 Trend — Near TRAMA
Price (1719.00), TRAMA-99 line (1735.05) at close levels (%-0.9). Important decision zone — breakout direction will determine the trend.
Price:: 1719.00
TRAMA: 1735.05
Difference: %-0.9
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
7733 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.